[ Price : $8.95]
Medical ethicist Arthur Caplan voices concerns about human subject protection in clinical trials due to significant staff cuts at ...[ Price : $8.95]
A Wiley Rein petition filed for a client asks FDA to order the immediate withdrawal of Wells Pharmas compounded 100 mg indomethaci...[ Price : $8.95]
FDA approves Shanghai Henlius Biologics Poherdy (pertuzumab-dpzb), the first interchangeable biosimilar to Genentechs Perjeta (per...[ Price : $8.95]
University of Chicago researchers explain how difficult it will be to improve government oversight over social media influencer pr...[ Price : $8.95]
FDA qualifies glutamate hydrogenase as a biomarker to enhance liver safety monitoring in clinical trials.[ Price : $8.95]
Gilead Sciences says its investigational single-tablet regimen combining bictegravir and lenacapavir met its primary endpoint in a...[ Price : $8.95]
FDA accepts for review an Outlook Therapeutics BLA resubmission for ONS-5010 (bevacizumab-vikg), an investigational ophthalmic for...[ Price : $8.95]
The CDER Office of Generic Drugs publishes a MAPP to help assessors use the four-part harmony approach in OGD-related communicatio...